HCA DCF Analysis: Intrinsic Value $740 vs Price $435
A Discounted Cash Flow (DCF) analysis for HCA Healthcare Inc (HCA) suggests the stock is undervalued, with an intrinsic value of $740.05 against a current price of $434.92. Both earnings-based and Free Cash Flow (FCF)-based DCF models, alongside the GF Value™, indicate undervaluation, while the GF Score™ reflects strong fundamentals despite a low predictability rank. Investors are cautioned about the low predictability and recent insider selling, although many gurus have increased their positions.
HCA Healthcare (NYSE:HCA) Keeps Patient Volumes Moving
HCA Healthcare (NYSE:HCA) is navigating a changing healthcare services landscape, focusing on maintaining strong patient volumes and optimizing its payer mix. The company faces pressures from higher borrowing costs, labor expenses, and evolving reimbursement policies, but continues to invest in capacity expansion and technology. Its financial strength and operational execution are key to long-term performance in a higher-rate environment.
DAI acquires 31 home health and hospice agencies from HCA in ‘unique opportunity’
Deaconess Associations Incorporated (DAI) has completed the acquisition of 31 home health and hospice agencies from HCA Healthcare, which will now join DAI's subsidiary, Central Pyramid. This acquisition expands Central Pyramid's geographic reach across eight states, reinforcing its nearly four decades of experience in home health and hospice care. According to DAI CEO Trey Crabb, this "unique opportunity" allows Central Pyramid to strengthen its presence and ability to serve more patients, with a focus on integration and organic growth rather than immediate further acquisitions.
Park National Corp OH Purchases 6,276 Shares of HCA Healthcare, Inc. $HCA
Park National Corp OH significantly increased its stake in HCA Healthcare, Inc. by 54.2% in the third quarter, acquiring 6,276 additional shares to reach a total of 17,851 shares valued at approximately $7.6 million. HCA Healthcare maintains a "Moderate Buy" consensus rating from analysts with an average price target of $463.70, following a quarter where it exceeded revenue and earnings estimates. The company also recently paid a quarterly dividend of $0.78 per share, representing an annualized yield of about 0.7%.
65,181 HCA Healthcare, Inc. $HCA Shares Sold by Argent Capital Management LLC
Argent Capital Management LLC reduced its stake in HCA Healthcare, Inc. by 36.8% in the third quarter, selling 65,181 shares. The firm now holds 112,176 shares, valued at approximately $47.87 million, making HCA Healthcare its 18th largest holding. Other institutional investors have also modified their holdings, while analysts maintain a "Moderate Buy" consensus rating for HCA Healthcare.
Can Operational Resiliency Protect HCA's Long-Term Profitability?
HCA Healthcare is leveraging a multi-year resiliency program to control costs and strengthen financial performance amidst significant earnings headwinds like health insurance exchange disenrollment. This program, focusing on digital transformation and productivity gains, aims to offset inflation and support long-term adjusted EBITDA growth of 4-6%. Peers like Tenet Healthcare and Universal Health Services are also implementing similar operational efficiency initiatives to maintain profitability in a challenging healthcare environment.
DAI Closes HCA Hospice, Home Health Transaction
Deaconess Associations Incorporated (DAI) has finalized its acquisition of 31 home health and hospice agencies from HCA Healthcare, including 24 home health and seven hospice locations across eight states. This move is part of DAI's strategy to expand its presence in home health and hospice care, with its subsidiary Central Pyramid operating the newly acquired facilities. The acquisition involved hiring approximately 1,000 HCA employees and aims to enhance access and support for patients receiving in-home care.
Raymond James rates HCA Healthcare stock Market Perform
Raymond James has initiated coverage of HCA Healthcare (HCA) with a Market Perform rating, citing industry headwinds such as Medicaid work requirements and spending caps. This cautious stance comes despite HCA Healthcare reporting strong second-quarter results, exceeding revenue and earnings forecasts. The next key event for investors will be the company's third-quarter earnings call scheduled for October 27, 2026, which will test the impact of these identified headwinds.
HCA Healthcare stock gets a USD 525.00 target as earnings near
Cantor Fitzgerald has reiterated an Overweight rating and a USD 525.00 price target for HCA Healthcare (HCA) ahead of its Q3 earnings call on October 27, 2026. This target is 22.9 percent above the stock's October 2 closing price of USD 427.09. Despite facing payer pressure and the expiration of certain payment program funds, HCA Healthcare reported strong Q2 2026 revenue of USD 20.23 billion and beat EPS consensus.
HCA Healthcare, Inc. Common Stock (NYSE:HCA) Stock Quote
This article provides a stock quote and detailed financial data for HCA Healthcare, Inc. (NYSE:HCA), including its current price, trading ranges, dividend yield, and historical performance compared to market indices. It also lists recent news headlines related to the company, such as earnings calls, acquisition announcements, and investor alerts from law firms. The article concludes with frequently asked questions about HCA Healthcare's stock.
CX Institutional Lowers Stock Holdings in HCA Healthcare, Inc. $HCA
CX Institutional significantly reduced its stake in HCA Healthcare (NYSE:HCA) by 69.0% in the third quarter, selling 15,257 shares and retaining 6,847 shares valued at $2.92 million. Despite this reduction by one institutional investor, other funds have been buying shares, and analysts maintain a "Moderate Buy" rating for HCA Healthcare with a consensus price target of $463.70. The company recently reported strong quarterly earnings and announced a dividend.
Dealbook: DAI Closes On HCA Deal; At Home Harmony Raises $4.7M
Deaconess Associations Incorporated (DAI) has acquired 24 home health and seven hospice locations from HCA Healthcare, expanding its reach across eight states. Separately, At Home Harmony secured $4.7 million in funding for its home-based primary care and other services, while Basalt Health raised $20 million in Series A funding for its AI-powered post-acute referral platform. These developments highlight significant investment and expansion within the home healthcare sector.
HCA Florida Healthcare program director details Graduate Medical Education
Dr. Amanda Finley, program director for internal medicine residency at HCA Florida Fort Walton-Destin Hospital, discusses Graduate Medical Education in the context of Florida's growing and aging population leading to a doctor shortage. HCA Florida Healthcare is a significant network in the state, aiming to address the need for expert medical care.
HCA closes home health, hospice sale to Deaconess
HCA Healthcare has completed the sale of 31 of its home health and hospice locations to Deaconess. The transaction was finalized on October 2, 2026, marking a significant change in HCA's post-acute care services. This move comes as health systems are also expanding other services to reduce reliance on emergency departments.
List of 28 Acquisitions by HCA (Oct 2026)
HCA has completed 28 acquisitions, with activity peaking in 2017 with six acquisitions. The most recent acquisition was CHCP in May 2026, a private college offering healthcare and medical courses. These acquisitions span two countries and six sectors, including Healthcare IT and Services for Healthcare Providers.
HCA Healthcare (NYSE:HCA) Stock Crosses Above Two Hundred Day Moving Average - Here's Why
HCA Healthcare (NYSE:HCA) shares recently surpassed their 200-day moving average, reaching $434.46 with a consensus "Moderate Buy" rating and an average analyst target of $463.70. The company reported strong Q1 2026 operating results, including an 8.7% year-over-year revenue increase to $20.23 billion and earnings of $7.59 per share, exceeding estimates. Despite positive developments like a new breast-health joint venture and AI tool expansion, investors face risks from a Pomerantz investigation and an ongoing contract dispute with Cigna in Houston.
HCA Healthcare brings back former exec to lead StoneSprings Hospital
HCA Healthcare has re-appointed its former chief operating officer, Ben Brown, as the new CEO of StoneSprings Hospital. This leadership change follows the hospital's decision to abandon plans for a new freestanding emergency room in Chantilly. The article also references related news about the hospital and HCA Healthcare.
Can THC's Cash Flow Support Its Expanding Capital-Return Strategy?
Tenet Healthcare Corporation (THC) is aggressively increasing its shareholder returns, backed by improved cash generation. The company significantly ramped up share buybacks in the first half of 2026 and raised its free cash flow guidance, while also balancing these returns with investments in growth initiatives and managing debt. The sustainability of this strategy depends on maintaining strong cash conversion and operational momentum to fund both growth and shareholder distributions.
UnitedHealth, Aetna, Humana roll out 2027 Medicare Advantage plans
UnitedHealth, Aetna, and Humana have begun rolling out their Medicare Advantage plans for the year 2027. The article, authored by Nona Tepper, was published on October 1, 2026, at 10:23 AM CDT.
HCA Houston and Cigna locked in new contract dispute with deal set to expire
HCA Houston Healthcare and Cigna are currently in a contract dispute, with their current agreement set to expire on October 1st. If a new deal is not reached, HCA's hospitals and surgical centers in Houston will no longer be part of Cigna's network. This standoff comes two years after their previous agreement was signed.
Victor Melo joins HCA Florida Woodmont Hospital as COO
Victor Melo has been appointed as the chief operating officer of HCA Florida Woodmont Hospital. He previously served as vice president of operations and ethics and compliance officer at HCA Florida Westside Hospital, where he contributed to strategic priorities, patient experience, and operational performance. Melo brings extensive operational expertise and leadership experience within HCA Florida Healthcare.
EBIT per share of HCA Healthcare Inc – HAN:2BH
This article displays the EBIT per share for HCA Healthcare Inc (HAN:2BH) on the TradingView platform. It provides a snapshot of the company's financial metric as observed on the Hannover Stock Exchange. The page is primarily a data display with navigation and platform-related information.
Comfort Systems USA (NYSE:FIX) Share Price Crosses Above Two Hundred Day Moving Average - Should You Sell?
Comfort Systems USA (NYSE:FIX) briefly traded above its 200-day moving average of $1,708.46, reaching $1,712.60 before settling at $1,663.68. The company reported strong Q2 earnings with EPS of $12.53 and 50.3% year-over-year revenue growth, and increased its quarterly dividend to $0.90. Despite a consensus "Buy" rating from analysts with an average target of $2,082.86, insiders have sold over $43 million in stock in the last 90 days.
Price to earnings forward of HCA Healthcare Inc – HAN:2BH
This article focuses on the "Price to earnings forward" metric for HCA Healthcare Inc (HAN:2BH) listed on the Hannover Stock Exchange. It appears to be a financial data page from TradingView, presenting the metric without providing specific values in the snippet. The content highlights HCA Healthcare Inc's presence in the Health Services sector under Hospital/Nursing Management.
HCA Healthcare presents 2026 Awards of Distinction
HCA Healthcare announced the recipients of its 2026 Awards of Distinction, recognizing outstanding colleagues, nurses, physicians, and volunteers who embody the organization's values. The awards include the Frist Humanitarian Award, which honors service to others, and the Excellence in Nursing Award, which introduced the new Sammie Mosier Leadership Award this year. These awards highlight individuals who demonstrate exceptional compassion, leadership, and dedication within their roles and communities.
A nurse helped save a woman at a hockey game. HCA Healthcare honored her for compassionate care.
HCA Healthcare presented its 2026 Awards of Distinction, honoring employees, physicians, volunteers, and nurses for their service and accomplishments. A new category, the Sammie Mosier Leadership Award, was introduced. Among the honorees, Zuzana Macis, an ER charge nurse, received the Excellence in Nursing Award for Compassionate Care, partly for saving a woman's life at a hockey game.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA
Pomerantz LLP has launched an investigation into HCA Healthcare, Inc. (NYSE: HCA) following a significant drop in its stock price. The investigation concerns potential securities fraud or unlawful business practices by HCA and its officers, specifically after the company lowered its full-year 2026 profit guidance due to an unfavorable shift in its payer mix, which impacted revenue by approximately $400 million in the second quarter. Investors are encouraged to contact the firm to learn more about joining a potential class action lawsuit.
Enterprise value to EBITDA ratio of HCA Healthcare Inc – HAN:2BH
This article displays the enterprise value to EBITDA ratio for HCA Healthcare Inc (HAN:2BH) on the TradingView platform. It notes that the market is closed with no trades recorded. The content is primarily a data page on a financial platform rather than a narrative article.
SOLIS MAMMOGRAPHY AND HCA HEALTHCARE CHARLESTON PARTNER TO EXPAND BREAST HEALTH SERVICES IN SOUTH CAROLINA
Solis Mammography and HCA Healthcare Trident Hospital have formed a joint venture to expand breast imaging services in the Charleston, South Carolina market, marking Solis Mammography's entry into its 26th major market. This partnership will integrate Trident Hospital's existing services under the Solis Mammography brand and aims to extend to other HCA Healthcare facilities in the future. The collaboration focuses on providing advanced breast health services, including 3D mammography with AI, to improve early detection and patient comfort in the Lowcountry.
HCA DCF Analysis: Intrinsic Value $740 vs Price $433
A DCF analysis for HCA Healthcare Inc (HCA) suggests the stock is undervalued, with an earnings-based intrinsic value of $740.05 against a current price of $432.60, offering a 41.5% margin of safety. The Free Cash Flow (FCF)-based model and GF Value™ also indicate undervaluation, though to a lesser degree. Despite a strong GF Score™ of 92/100, the low predictability rank of 2/5 stars suggests that the DCF model's reliability for HCA may be limited, and recent insider selling could be a cautionary signal for investors.
Can HCA Healthcare (HCA) Overcome Healthcare’s Margin Pressures?
BMO Capital initiated coverage on HCA Healthcare (HCA) with an Outperform rating and a $495 price target, citing demographic-driven growth and efficiency initiatives. While HCA benefits from operational scale and secular demand, it faces risks from unfavorable payer shifts, softer surgical volumes, and high debt levels. The report highlights BMO's confidence in HCA's market position, despite near-term earnings friction.
HCA's StoneSprings Hospital drops plan for freestanding ER in Chantilly
HCA Healthcare's StoneSprings Hospital has abandoned its plan to open a freestanding emergency room in Chantilly. The hospital had intended to purchase a former deli to convert into an 11-room ER, but the property is now being marketed for $7 million. This decision comes after the hospital had been under contract for the acquisition.
HCA Healthcare stock trades at USD 439.00 as BMO sets USD 495.00 target
HCA Healthcare (HCA) stock is trading at USD 439.00 after BMO Capital initiated coverage with an Outperform rating and a USD 495.00 price target. This target represents a 12.76% upside from the current intraday price. The company reported Q2 2026 revenue of USD 20.23 billion, an 8.70% increase year-over-year, and adjusted EPS of USD 7.59, surpassing forecasts, though its full-year profit guidance was lowered due to changes in payer mix.
Raymond James assumes Market Perform on HCA Healthcare stock citing industry headwinds
Raymond James initiated coverage on HCA Healthcare (NYSE:HCA) with a Market Perform rating, acknowledging potential upside from the stock trading below its InvestingPro Fair Value despite near-term industry challenges. The firm highlighted headwinds such as Medicaid work requirements, SDP caps, and unfavorable exchange trends, noting that HCA, as the largest public hospital franchise, is well-positioned to navigate these issues. The analyst firm also pointed out that HCA's P/E ratio of 14.49 is low relative to its near-term earnings growth.
Raymond James assumes Market Perform on HCA Healthcare stock citing industry headwinds
Raymond James initiated coverage on HCA Healthcare Inc. (NYSE:HCA) with a Market Perform rating, citing near-term industry challenges despite the stock trading below its InvestingPro Fair Value. The firm highlighted headwinds such as Medicaid work requirements, SDP caps, and unfavorable exchange trends, although HCA, as the largest public hospital franchise, is expected to navigate these. Analysts noted mixed year-to-date execution for HCA and anticipate a period of below-historical growth, making the current P/E ratio less accommodating, even though the company recently surpassed Q2 2026 earnings and revenue expectations.
Medical Properties Trust Forms Warning Pattern
Medical Properties Trust (MPT) stock is underperforming the market, dropping to a low of $3.57 and forming an inverted cup-and-handle pattern, suggesting further downside. The company faces significant challenges, including tenant bankruptcies, struggles to collect rent, and the need to cut dividends and sell assets. Rising bond yields have also contributed to the stock's slump, leading analysts to reduce their price targets.
Cryoport shares jump 82% YTD on strong cell and gene therapy pipeline and profitability rebound
Cryoport (CYRX) stock has surged 82% year-to-date due to strong growth in cell and gene therapy commercialization and a robust pipeline. The company achieved adjusted EBITDA profitability in Q2 2026, supported by Life Science Services growth and positive operating cash flow. Management expects five new therapy approvals in 2026 and a 15% increase in Phase 3 trials, while maintaining a net cash position despite potential FDA rejections and biotech funding slowdowns.
Hope Fund Week 2026: Colleagues caring for each other when they need it most
The HCA Healthcare Hope Fund provides financial assistance to HCA Healthcare colleagues and their families facing unexpected events like illness, injury, and natural disasters. Since its inception in 2005, the fund has distributed over $132 million to more than 52,000 colleagues. This article highlights five stories of HCA Healthcare colleagues who received crucial support from the Hope Fund during challenging times, emphasizing the fund's role in fostering a supportive community within the organization.
Expert Voices: HCA Healthcare physician shares how pulsed field ablation is transforming atrial fibrillation care
Dr. John Day, an HCA Healthcare cardiac electrophysiologist, highlights pulsed field ablation as a groundbreaking treatment for atrial fibrillation (AFib), making procedures faster, safer, and more effective. HCA Healthcare physicians are actively involved in research to refine this technology and improve patient outcomes. The article emphasizes the importance of recognizing AFib symptoms and seeking early evaluation due to its links to stroke, heart failure, and dementia.
Can Community Health Sustain Growth as Elective Demand Softens?
Community Health Systems (CYH) faces challenges in sustaining growth despite increasing patient volumes, primarily due to a weak payer mix with a high percentage of uninsured patients and soft demand for elective procedures. While some demand for elective care appears delayed rather than lost, the company's financial performance was impacted by unfavorable payer mix, higher uncompensated care, and increased specialist fees. Peers like HCA Healthcare and Tenet Healthcare showed stronger revenue growth, indicating the critical role of payer mix and procedure intensity in the healthcare sector.
Can Community Health Sustain Growth as Elective Demand Softens?
Community Health Systems (CYH) is experiencing volume growth, primarily driven by uninsured patients, which is limiting revenue benefits. The company's ability to sustain growth and improve margins depends on a recovery in commercially insured elective procedures and a better payer mix. While elective surgeries remain soft, improved June surgery volumes and strong clinic visits suggest delayed rather than lost demand, and CYH is projecting 2026 revenues of $11.4-$11.6 billion and adjusted EBITDA of $1.30-$1.375 billion.
Solid Biosciences is a speculative buy with promising gene therapy and cash runway into 2028
Solid Biosciences is considered a speculative buy due to its SGT-003 gene therapy for Duchenne muscular dystrophy and a strong cash runway extending to mid-2028. The company aims to differentiate itself from competitors by demonstrating clear biological and functional benefits to doctors and regulators. Success hinges on proving advantages in treatment, safety, and patient eligibility amidst market competition.
This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
BMO Capital initiated coverage on HCA Healthcare with an Outperform rating and a $495 price target. Other analysts also started coverage on Guardian Pharmacy Services, Toro Co, Marvell Technology Inc, and Pulse Biosciences Inc with bullish ratings and specific price targets. These initiations reflect positive outlooks from top Wall Street analysts on the respective companies.
Tenet Healthcare (THC) Refinances $2.0b Of Debt, Is The Stock Still Cheap?
Tenet Healthcare (THC) recently refinanced $2.0 billion of debt, issuing new 6.250% senior notes due 2034 to redeem earlier debt. Despite strong long-term share price performance, the stock has seen short-term cooling and trades below analyst targets, raising questions about whether it's undervalued or if the discount reflects lingering risks. The company's focus on cost efficiency and strategic capital deployment, including M&A and share repurchases, aims to sustain free cash flow and improve leverage.
Cash Flow Improvement Could Be A Game Changer For Acadia Healthcare (ACHC)
Acadia Healthcare Company (ACHC) is showing stronger cash generation due to maturing psychiatric and specialty treatment facilities, disciplined capital spending, and new joint-venture hospitals. This improved cash flow is expected to support debt reduction and lead to positive free cash flow in the second half of 2026. The shift from headline capacity growth to actual cash generation provides a clearer investment narrative, though risks like Medicaid reimbursement pressures and underperforming facilities remain.
Travel sellers react to Royal Caribbean-Sandals partnership
Travel sellers are expressing optimism about the new joint venture between Royal Caribbean Group and Sandals Resorts, viewing it as an opportunity for new experiences for guests both on land and at sea. The partnership is seen as beneficial for travel advisors, offering new options for clients and enhancing the trade-friendly nature of both brands. This collaboration reinforces Royal Caribbean's positioning as a broader vacation experience company, not just a cruise line.
HCA Healthcare invests more than $32 M in Mission Health facilities across WNC
HCA Healthcare is investing over $32 million in Mission Health facilities across Western North Carolina to enhance patient care. This significant investment includes nearly $15 million for imaging and diagnostic technology and more than $13 million for surgical, cardiovascular, and procedural care. The initiative aims to strengthen the safety, quality, and capabilities of care by providing advanced equipment and technology to physicians and care teams throughout the region.
HCA Healthcare faces securities fraud investiga...
HCA Healthcare is under investigation for securities fraud after significantly cutting its full-year 2026 profit guidance, which led to a nearly 7% stock drop. The cut was attributed to an unfavorable shift in its payer mix, resulting in a $400 million revenue reduction in Q2. Pomerantz LLP is investigating potential unlawful practices, and affected investors are encouraged to contact the law firm for class action participation.
BrightSpring Health Services (BTSG) Short Interest & Short Float | Updated Sep 2026
As of September 15, 2026, BrightSpring Health Services (BTSG) had a short interest of 10.18 million shares, representing 5.30% of its public float, which is a 0.36% increase from the prior report. The short interest ratio is 4.6 days to cover, indicating it would take 4.6 days of average trading volume to cover all short positions. The article provides a historical table of short interest data and answers frequently asked questions about BTSG's short interest metrics and comparison to competitors.
Five Texas Hospitals Tied to HCA Sue Independence Blue Cross Over $345,000 in Denied Claims, Including Emergency Care
Five HCA-affiliated hospitals in Texas have sued Independence Blue Cross, a Philadelphia-based insurer, over $345,000 in allegedly denied or underpaid claims for eight members, including emergency care. The lawsuit claims the insurer violated federal and state law by requiring prior authorization for emergency services and failing to provide specific clinical reasons for denials. This dispute highlights ongoing issues within the BlueCard Program regarding varying authorization rules and medical necessity standards across different Blue Cross Blue Shield plans.
